
Fermenta Biotech Ltd is Rated Strong Sell
2026-05-23 10:10:18Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Apr 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 23 May 2026, providing investors with the latest perspective on the company’s position.
Read full news articleWhen is the next results date for Fermenta Biotech Ltd?
2026-05-20 23:18:22The next results date for Fermenta Biotech Ltd is scheduled for 26 May 2026....
Read full news article
Fermenta Biotech Ltd is Rated Strong Sell
2026-05-12 10:10:25Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Fermenta Biotech Ltd Locks at Lower Circuit With 20% Loss — Sellers Queue, No Buyers in Sight
2026-05-04 14:00:06At Rs 248.85, sellers were still queuing — but there were no buyers willing to take the other side. Fermenta Biotech Ltd locked at its lower circuit of 20% on 4 May 2026, with unfilled sell orders and a frozen price that capped losses for the day.
Read full news article
Fermenta Biotech Ltd is Rated Strong Sell
2026-05-01 10:10:17Fermenta Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Apr 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 01 May 2026, providing investors with the latest perspective on the company’s position.
Read full news article
Fermenta Biotech Downgraded to Strong Sell Amid Mixed Valuation and Weak Financial Trends
2026-04-20 08:11:13Fermenta Biotech Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 17 April 2026, driven by a complex interplay of valuation improvements, deteriorating financial trends, weak quality metrics, and unfavourable technical signals. Despite a very attractive valuation profile, the company’s long-term fundamentals and recent quarterly performance have raised significant concerns among analysts, prompting a reassessment of its investment appeal.
Read full news article
Fermenta Biotech Ltd is Rated Sell
2026-04-17 10:10:03Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Fermenta Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-04-15 08:00:33Fermenta Biotech Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite recent market headwinds and a downgrade in its overall mojo grade to Sell. This change reflects a notable improvement in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap pharmaceutical and biotechnology firm as a compelling value proposition relative to its peers and historical benchmarks.
Read full news article
Fermenta Biotech Ltd is Rated Sell
2026-04-06 10:10:03Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleBoard Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Consideration Of Final Equity Dividend If Any.
19-May-2026 | Source : BSEFermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31 2026 and consideration of final equity dividend if any.
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-May-2026 | Source : BSEPublication of IEPF related notice for equity shareholders
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
28-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Fermenta Biotech Ltd |
| 2 | CIN NO. | L99999MH1951PLC008485 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 17.39 |
| 4 | Highest Credit Rating during the previous FY | CAREBBBSTABLE |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | CARE RATINGS LIMITED |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Designation: COMPANY SECRETARY AND HEAD LEGAL
EmailId: varadvinayak.khambete@fermentabiotech.com
Designation: CHIEF FINANCIAL OFFICER
EmailId: sumesh.gandhi@fermentabiotech.com
Date: 28/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Corporate Actions
26 May 2026
Fermenta Biotech Ltd has declared 50% dividend, ex-date: 06 Aug 25
Fermenta Biotech Ltd has announced 5:5 stock split, ex-date: 08 Aug 18
Fermenta Biotech Ltd has announced 2:1 bonus issue, ex-date: 13 Feb 20
No Rights history available






